MedPath

The clinical efficacy research and Intestinal flora of Wu-Mei-Wan Decoction in treatment of early awakening insomnia

Phase 1
Conditions
early awakening insomnia
Registration Number
ITMCTR2000003357
Lead Sponsor
inyi City People's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) in line with the western medicine diagnostic criteria for insomnia
(2) in accordance with the clinical manifestations of early awakening: sleep awakening time than normal time above 30 min in advance, or wake up earlier than usual 1 ~ 2 h, the total sleep time is less than 6 h; Includes the following 1 to several items: extremities cold, apex pain, thirst, hunger, restlessness and restlessness.
(3) the total PSQI score was > and 7;
(4) between the ages of 18 and 60, both male and female;
(5) to understand the clinical observation significance of this drug, actively cooperate with the clinical follow-up and clinical evaluation of the researchers engaged in this drug, and have good compliance;
(6) patients voluntarily participate in this study with full knowledge;
(7) drugs that damage liver and kidney functions have not been applied within 3 months;
(8) denied participating in other treatments within 3 months;
(9) have not taken any sedatives within one week;
(10) those who are conscious, agree and able to cooperate in collecting clinical data.

Exclusion Criteria

(1) patients with insomnia who complained of multiple dreams and impaired shallow social function;
(2) excluding secondary insomnia: insomnia caused by systemic diseases such as pain, fever, cough, surgery, external interference, etc., as well as insomnia caused by physical diseases or mental disorders, such as depression; Anxiety disorder; People with mental illness;
(3) patients with serious primary and serious organic diseases including heart, cerebrovascular, lung, liver, kidney and hematopoietic system;
(4) patients with allergic constitution;
(5) women during pregnancy and lactation;
(6) patients with alcohol and drug dependence and substance abuse;
(7) patients with decompensated respiratory dysfunction, myasthenia gravis and severe sleep apnea.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PSQI;Quality of life scale of traditional Chinese Medicine;intestinal flora;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath